Estrone-A en es it fr

Estrone-A Brand names, Estrone-A Analogs

Estrone-A Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Estrone-A Chemical_Formula

C18H22O2

Estrone-A RX_link

No information avaliable

Estrone-A fda sheet

Estrone-A msds (material safety sheet)

Estrone-A MSDS

Estrone-A Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Estrone-A Molecular Weight

270.366 g/mol

Estrone-A Melting Point

254.5-256 oC

Estrone-A H2O Solubility

3 g/100mL

Estrone-A State

Solid

Estrone-A LogP

4.067

Estrone-A Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Estrone-A Indication

For management of Menopausal and postmenopausal disorders

Estrone-A Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Estrone-A Absorption

43%

Estrone-A side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Estrone-A Patient Information

Estrone-A Organisms Affected

Humans and other mammals